Find recruiting clinical trials for hepatitis in the UK — including hepatitis B, hepatitis C, and autoimmune hepatitis. See treatment pathways and where trials fit in.
Free to use — Live data from ClinicalTrials.gov — Updated hourly
Answer a few questions about your condition and we'll match you to the most relevant clinical trials.
See where clinical trials fit into your treatment journey
Chronic HBV management
Standard: Entecavir or Tenofovir (antiviral tablets) for viral suppression
Functional cure research
Standard: RNA interference, capsid inhibitors, or therapeutic vaccines
Direct-acting antivirals
Standard: Sofosbuvir/Velpatasvir (Epclusa) — 95%+ cure rate in 8-12 weeks
Immune-mediated liver inflammation
Standard: Prednisolone + Azathioprine, or Mycophenolate
Chronic viral infection of the liver. Treatments can suppress the virus effectively, but a functional cure (clearing the virus) remains elusive — many trials aim to achieve this.
Curable with modern direct-acting antivirals in 95%+ of cases. However, many people remain undiagnosed. Trials focus on simplified treatment, reinfection, and special populations.
The immune system attacks the liver. Requires long-term immunosuppression. Some patients are difficult to manage and may benefit from clinical trials.
Loading trials from ClinicalTrials.gov...
Yes. Modern direct-acting antivirals (DAAs) cure hepatitis C in over 95% of cases with 8-12 weeks of tablets. Trials are studying even shorter courses and simplified treatment pathways.
A functional cure means sustained loss of hepatitis B surface antigen (HBsAg) without ongoing treatment. Current trials are testing RNA interference, capsid assembly modulators, and therapeutic vaccines to achieve this.
Yes. Hepatitis B and C are more common in people with HIV, and several UK trials specifically study co-infection treatment approaches, drug interactions, and outcomes.
Use our search above to find trials that match your condition and location. Review the eligibility criteria carefully.
Talk to your GP or specialist about any trials you are interested in. They can help determine if a trial is appropriate for you.
Reach out to the trial team directly using the contact information on the ClinicalTrials.gov listing. They will guide you through screening.
If you meet the criteria and decide to participate, you will go through informed consent and begin the trial process.